COMBINATION THERAPY OF INSULINOTROPIC PEPTIDE AND GLP-2, FOR PREVENTING OR TREATING SHORT BOWEL SYNDROME

Title:

COMBINATION THERAPY OF INSULINOTROPIC PEPTIDE AND GLP-2, FOR PREVENTING OR TREATING SHORT BOWEL SYNDROME

Document Type and Number:

WIPO Patent Application WO/2022/139552

Kind Code:

A1

Abstract:

The present invention relates to a combination therapy of insulinotropic peptide and GLP-2, for preventing, alleviating or treating short bowel syndrome.

Inventors:

CHOI JAE HYUK (KR)
LEE JIN BONG (KR)
LEE SANG HYUN (KR)
KWON HYUN JOO (KR)
HONG SUNG HEE (KR)
YOO NYEONG SANG (KR)

Application Number:

PCT/KR2021/019854

Publication Date:

June 30, 2022

Filing Date:

December 24, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

HANMI PHARM IND CO LTD (KR)

International Classes:

A61K38/26; A61K38/22; A61K47/68; A61P1/00; A61P29/00; C07K14/605

Domestic Patent References:

WO1997034631A1	1997-09-25
WO1996032478A1	1996-10-17

Foreign References:

KR20110110174A	2011-10-06
KR20190037181A	2019-04-05
JP2014058528A	2014-04-03
JP2011506442A	2011-03-03
US5424286A	1995-06-13
KR20190037181A	2019-04-05

Other References:

K.B. MADSEN, C. ASKOV-HANSEN, R.M. NAIMI, C.F. BRANDT, B. HARTMANN, J.J. HOLST, P.B. MORTENSEN, P.B. JEPPESEN: "Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study", REGULATORY PEPTIDES, ELSEVIER, vol. 184, 1 June 2013 (2013-06-01), pages 30 - 39, XP055183143, ISSN: 01670115, DOI: 10.1016/j.regpep.2013.03.025
LJUNGMANN K. ET AL., AM. J. PHYSIOL. GASTROINTEST LIVER PHYSIOL., vol. 281, no. 3, 2001, pages G779 - 85

Attorney, Agent or Firm:

HANOL INTELLECTUAL PROPERTY & LAW (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: TIMER OPERATING METHOD AND DEVICE ACCORDING TO HARQ ACTIVATION

Next Patent: VACUUM CLEANER AND METHOD FOR CONTROLLING SAME